VSTM VERASTEM INC More: the full row for VERASTEM INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 870,000 shares; 2025Q1: 613,000 shares; 2025Q2: 1,360,386 shares; 2025Q3: 2,670,032 shares; 2025Q4: 2,732,079 shares; 2026Q1: 3,302,300 shares; 2026Q2: 3,349,627 shares; 2026Q3: 3,042,775 shares 3,042,775 $24.5M 20.45% -306,852 Timeline CAMP CAMP4 THERAPEUTICS CORP More: the full row for CAMP4 THERAPEUTICS CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 228,894 shares; 2026Q1: 1,389,622 shares; 2026Q2: 1,389,622 shares; 2026Q3: 2,786,249 shares 2,786,249 $11.3M 9.4% +1,396,627 Timeline EOLS EVOLUS INC More: the full row for EVOLUS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,264,651 shares; 2025Q1: 1,134,574 shares; 2025Q2: 916,500 shares; 2025Q3: 1,536,391 shares; 2025Q4: 1,631,588 shares; 2026Q1: 1,759,091 shares; 2026Q2: 1,590,162 shares; 2026Q3: 971,622 shares 971,622 $7.77M 6.49% -618,540 Timeline ADMA ADMA BIOLOGICS INC More: the full row for ADMA BIOLOGICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,241,032 shares; 2025Q1: 810,000 shares; 2025Q2: 750,000 shares; 2025Q3: 739,000 shares; 2025Q4: 740,000 shares; 2026Q1: 740,000 shares; 2026Q2: 740,000 shares; 2026Q3: 700,000 shares 700,000 $7.02M 5.86% -40,000 Timeline NKTR NEKTAR THERAPEUTICS More: the full row for NEKTAR THERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 50,200 shares; 2025Q3: 85,000 shares; 2025Q4: 85,000 shares; 2026Q1: 85,000 shares; 2026Q2: 120,654 shares; 2026Q3: 110,000 shares 110,000 $6.66M 5.56% -10,654 Timeline ELOX ELOXX PHARMACEUTICALS INC More: the full row for ELOXX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 397,160 shares; 2026Q3: 381,977 shares 381,977 $5.85M 4.88% -15,183 Timeline MSLE SATELLOS BIOSCIENCE INC More: the full row for SATELLOS BIOSCIENCE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 100,000 shares; 2026Q2: 491,624 shares; 2026Q3: 455,058 shares 455,058 $3.87M 3.23% -36,566 Timeline KZIA KAZIA THERAPEUTICS LTD More: the full row for KAZIA THERAPEUTICS LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 460,359 shares; 2026Q1: 345,179 shares; 2026Q2: 345,179 shares; 2026Q3: 377,429 shares 377,429 $3.62M 3.02% +32,250 Timeline INDV INDIVIOR PHARMACEUTICALS INC More: the full row for INDIVIOR PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 100,000 shares; 2026Q3: 100,000 shares 100,000 $3.58M 2.99% 0 Timeline RARE ULTRAGENYX PHARMACEUTICAL IN More: the full row for ULTRAGENYX PHARMACEUTICAL IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 20,000 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 25,000 shares; 2026Q3: 210,000 shares 210,000 $3.16M 2.64% +185,000 Timeline EDSA EDESA BIOTECH INC More: the full row for EDESA BIOTECH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 687,500 shares; 2025Q2: not reported; 2025Q3: 687,500 shares; 2025Q4: 687,500 shares; 2026Q1: 30,000 shares; 2026Q2: 456,439 shares; 2026Q3: 710,266 shares 710,266 $2.99M 2.5% +253,827 Timeline BSX BOSTON SCIENTIFIC CORP More: the full row for BOSTON SCIENTIFIC CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 55,000 shares 55,000 $2.4M 2% new Timeline AYTU AYTU BIOPHARMA INC More: the full row for AYTU BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 407,549 shares; 2025Q1: 463,721 shares; 2025Q2: 812,676 shares; 2025Q3: 891,855 shares; 2025Q4: 813,704 shares; 2026Q1: 792,289 shares; 2026Q2: 912,921 shares; 2026Q3: 964,900 shares 964,900 $2.06M 1.72% +51,979 Timeline ANTX AN2 THERAPEUTICS INC More: the full row for AN2 THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 196,732 shares; 2025Q1: not reported; 2025Q2: 544,494 shares; 2025Q3: 563,913 shares; 2025Q4: 627,668 shares; 2026Q1: 713,845 shares; 2026Q2: 551,692 shares; 2026Q3: 350,877 shares 350,877 $1.87M 1.56% -200,815 Timeline XLO XILIO THERAPEUTICS INC More: the full row for XILIO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 64,162 shares; 2026Q2: 225,994 shares; 2026Q3: 189,092 shares 189,092 $1.71M 1.43% -36,902 Timeline PYXS PYXIS ONCOLOGY INC More: the full row for PYXIS ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 689,000 shares 689,000 $1.61M 1.34% new Timeline ABEO ABEONA THERAPEUTICS INC More: the full row for ABEONA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 45,000 shares; 2025Q3: 450,970 shares; 2025Q4: 709,505 shares; 2026Q1: 746,587 shares; 2026Q2: 557,284 shares; 2026Q3: 282,016 shares 282,016 $1.48M 1.24% -275,268 Timeline SRZN SURROZEN INC More: the full row for SURROZEN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 137,200 shares; 2025Q1: 285,782 shares; 2025Q2: 306,029 shares; 2025Q3: 250,146 shares; 2025Q4: 113,631 shares; 2026Q1: 33,005 shares; 2026Q2: not reported; 2026Q3: 44,100 shares 44,100 $1.42M 1.18% new Timeline CLRB CELLECTAR BIOSCIENCES INC More: the full row for CELLECTAR BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 104,550 shares; 2026Q3: 749,028 shares 749,028 $1.38M 1.15% +644,478 Timeline KTTA PASITHEA THERAPEUTICS CORP More: the full row for PASITHEA THERAPEUTICS CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 275,062 shares; 2026Q1: 831,301 shares; 2026Q2: 2,201,468 shares; 2026Q3: 2,774,234 shares 2,774,234 $1.37M 1.14% +572,766 Timeline ACET ADICET BIO INC More: the full row for ADICET BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 220,011 shares; 2026Q1: 221,955 shares; 2026Q2: 245,518 shares; 2026Q3: 188,201 shares 188,201 $1.34M 1.12% -57,317 Timeline IKT INHIBIKASE THERAPEUTICS INC More: the full row for INHIBIKASE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,132,388 shares; 2025Q1: 914,973 shares; 2025Q2: 733,793 shares; 2025Q3: 735,019 shares; 2025Q4: 2,348,147 shares; 2026Q1: 957,202 shares; 2026Q2: 396,179 shares; 2026Q3: 647,285 shares 647,285 $1.33M 1.11% +251,106 Timeline OKYO OKYO PHARMA LTD More: the full row for OKYO PHARMA LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 850,000 shares; 2026Q2: 862,996 shares; 2026Q3: 914,367 shares 914,367 $1.18M 0.98% +51,371 Timeline QNRX QUOIN PHARMACEUTICALS LTD More: the full row for QUOIN PHARMACEUTICALS LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 78,189 shares; 2026Q1: 53,460 shares; 2026Q2: 199,486 shares; 2026Q3: 252,434 shares 252,434 $1.15M 0.96% +52,948 Timeline TENX TENAX THERAPEUTICS INC More: the full row for TENAX THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 11,884 shares; 2026Q1: 975,200 shares; 2026Q2: 660,000 shares; 2026Q3: 588,000 shares 588,000 $1.11M 0.93% -72,000 Timeline ZVRA ZEVRA THERAPEUTICS INC More: the full row for ZEVRA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 597,700 shares; 2025Q1: 650,000 shares; 2025Q2: 775,620 shares; 2025Q3: 810,000 shares; 2025Q4: 569,088 shares; 2026Q1: 480,000 shares; 2026Q2: 258,701 shares; 2026Q3: 100,000 shares 100,000 $1.1M 0.92% -158,701 Timeline CABA CABALETTA BIO INC More: the full row for CABALETTA BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 171,100 shares; 2026Q1: 50,000 shares; 2026Q2: 917,100 shares; 2026Q3: 520,000 shares 520,000 $998K 0.83% -397,100 Timeline CDXS CODEXIS INC More: the full row for CODEXIS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 88,264 shares; 2025Q4: 256,106 shares; 2026Q1: 417,994 shares; 2026Q2: 109,662 shares; 2026Q3: 676,973 shares 676,973 $941K 0.79% +567,311 Timeline INAB IN8BIO INC More: the full row for IN8BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 82,430 shares; 2025Q3: 159,421 shares; 2025Q4: 164,893 shares; 2026Q1: 663,412 shares; 2026Q2: 695,287 shares; 2026Q3: 697,852 shares 697,852 $928K 0.77% +2,565 Timeline GOSS GOSSAMER BIO INC More: the full row for GOSSAMER BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 63,039 shares 63,039 $747K 0.62% new Timeline XENE XENON PHARMACEUTICALS INC More: the full row for XENON PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 20,000 shares 20,000 $744K 0.62% new Timeline AZTR AZITRA INC More: the full row for AZITRA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 5,285,476 shares; 2026Q3: 5,227,438 shares 5,227,438 $719K 0.6% -58,038 Timeline FEMY FEMASYS INC More: the full row for FEMASYS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 326,770 shares 326,770 $706K 0.59% new Timeline ZNTL ZENTALIS PHARMACEUTICALS INC More: the full row for ZENTALIS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 60,000 shares; 2025Q2: 109,010 shares; 2025Q3: 453,800 shares; 2025Q4: 463,700 shares; 2026Q1: 269,100 shares; 2026Q2: 161,583 shares; 2026Q3: 254,759 shares 254,759 $706K 0.59% +93,176 Timeline MLTX MOONLAKE IMMUNOTHERAPEUTICS More: the full row for MOONLAKE IMMUNOTHERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 50,000 shares; 2026Q3: 60,000 shares 60,000 $702K 0.59% +10,000 Timeline CRBP CORBUS PHARMACEUTICALS HLDGS More: the full row for CORBUS PHARMACEUTICALS HLDGS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 35,000 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 389,916 shares; 2026Q1: 383,462 shares; 2026Q2: 425,000 shares; 2026Q3: 95,000 shares 95,000 $648K 0.54% -330,000 Timeline AEON AEON BIOPHARMA INC More: the full row for AEON BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,125,748 shares 2,125,748 $638K 0.53% new Timeline ALMS ALUMIS INC More: the full row for ALUMIS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 349,615 shares; 2025Q3: 300,000 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 85,000 shares 85,000 $628K 0.52% new Timeline CTMX CYTOMX THERAPEUTICS INC. More: the full row for CYTOMX THERAPEUTICS INC. Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 125,000 shares; 2025Q4: not reported; 2026Q1: 200,000 shares; 2026Q2: 205,000 shares; 2026Q3: 220,000 shares 220,000 $598K 0.5% +15,000 Timeline SINT SINTX TECHNOLOGIES INC More: the full row for SINTX TECHNOLOGIES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 209,205 shares; 2026Q3: 233,936 shares 233,936 $522K 0.44% +24,731 Timeline ZLAB ZAI LAB LTD More: the full row for ZAI LAB LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 18,998 shares 18,998 $500K 0.42% new Timeline IRD OPUS GENETICS INC More: the full row for OPUS GENETICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 68,688 shares; 2026Q2: 100,718 shares; 2026Q3: 98,147 shares 98,147 $475K 0.4% -2,571 Timeline NMRA NEUMORA THERAPEUTICS INC. More: the full row for NEUMORA THERAPEUTICS INC. Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 100,000 shares; 2026Q2: not reported; 2026Q3: 787,269 shares 787,269 $469K 0.39% new Timeline CALC CALCIMEDICA INC More: the full row for CALCIMEDICA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 278,680 shares 278,680 $451K 0.38% new Timeline PLRX PLIANT THERAPEUTICS INC More: the full row for PLIANT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 289,237 shares; 2025Q4: 230,050 shares; 2026Q1: 224,650 shares; 2026Q2: 230,538 shares; 2026Q3: 414,903 shares 414,903 $448K 0.37% +184,365 Timeline OKUR ONKURE THERAPEUTICS INC More: the full row for ONKURE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 132,578 shares; 2026Q2: 130,684 shares; 2026Q3: 162,818 shares 162,818 $444K 0.37% +32,134 Timeline XFOR X4 PHARMACEUTICALS INC More: the full row for X4 PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,056,338 shares; 2025Q4: 593,573 shares; 2026Q1: 335,309 shares; 2026Q2: 224,989 shares; 2026Q3: 150,000 shares 150,000 $435K 0.36% -74,989 Timeline NGEN NERVGEN PHARMA CORP More: the full row for NERVGEN PHARMA CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 271,678 shares; 2026Q3: 200,000 shares 200,000 $382K 0.32% -71,678 Timeline EPRX EUPRAXIA PHARMACEUTICALS INC More: the full row for EUPRAXIA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 43,491 shares; 2026Q3: 40,000 shares 40,000 $364K 0.3% -3,491 Timeline SABS SAB BIOTHERAPEUTICS INC More: the full row for SAB BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 50,000 shares; 2026Q2: 73,271 shares; 2026Q3: 88,108 shares 88,108 $279K 0.23% +14,837 Timeline IMA IMAGENEBIO INC More: the full row for IMAGENEBIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 57,663 shares 57,663 $264K 0.22% new Timeline QTTB Q32 BIO INC More: the full row for Q32 BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 31,200 shares 31,200 $258K 0.22% new Timeline QTI QT IMAGING HLDGS INC More: the full row for QT IMAGING HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 100,000 shares; 2026Q3: 100,000 shares 100,000 $254K 0.21% 0 Timeline MXCT MAXCYTE INC More: the full row for MAXCYTE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 459,018 shares; 2025Q4: 469,018 shares; 2026Q1: 1,004,673 shares; 2026Q2: 751,606 shares; 2026Q3: 224,881 shares 224,881 $252K 0.21% -526,725 Timeline CNSP CNS PHARMACEUTICALS INC More: the full row for CNS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 48,827 shares; 2026Q1: 61,000 shares; 2026Q2: 41,573 shares; 2026Q3: 39,942 shares 39,942 $212K 0.18% -1,631 Timeline LUNG PULMONX CORP More: the full row for PULMONX CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 145,900 shares; 2025Q3: 670,000 shares; 2025Q4: 486,400 shares; 2026Q1: 768,288 shares; 2026Q2: 815,436 shares; 2026Q3: 110,479 shares 110,479 $211K 0.18% -704,957 Timeline EYPT EYEPOINT INC More: the full row for EYEPOINT INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 55,000 shares 55,000 $180K 0.15% new Timeline ARDX ARDELYX INC More: the full row for ARDELYX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 555,000 shares; 2025Q3: 200,000 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 51,000 shares 51,000 $174K 0.15% new Timeline OCUL OCULAR THERAPEUTIX INC More: the full row for OCULAR THERAPEUTIX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 20,000 shares 20,000 $153K 0.13% new Timeline BOLD BOUNDLESS BIO INC More: the full row for BOUNDLESS BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 106,175 shares; 2025Q3: 413,453 shares; 2025Q4: 710,071 shares; 2026Q1: 597,682 shares; 2026Q2: 154,595 shares; 2026Q3: 52,547 shares 52,547 $132K 0.11% -102,048 Timeline CLYM CLIMB BIO INC More: the full row for CLIMB BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 116,147 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 10,000 shares 10,000 $115K 0.1% new Timeline KLRS KALARIS THERAPEUTICS INC More: the full row for KALARIS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 20,400 shares; 2026Q2: 30,122 shares; 2026Q3: 33,842 shares 33,842 $97.8K 0.08% +3,720 Timeline BIOA BIOAGE LABS INC More: the full row for BIOAGE LABS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 50,000 shares; 2025Q2: 151,085 shares; 2025Q3: 188,571 shares; 2025Q4: 45,000 shares; 2026Q1: 50,000 shares; 2026Q2: 20,000 shares; 2026Q3: 11,948 shares 11,948 $84.7K 0.07% -8,052 Timeline CNTB CONNECT BIOPHARMA HLDGS LTD More: the full row for CONNECT BIOPHARMA HLDGS LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 310,000 shares; 2026Q2: 364,254 shares; 2026Q3: 49,468 shares 49,468 $54.4K 0.05% -314,786 Timeline EVAX EVAXION AS More: the full row for EVAXION AS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 20,000 shares; 2026Q1: 19,713 shares; 2026Q2: 17,562 shares; 2026Q3: 16,566 shares 16,566 $54.3K 0.05% -996 Timeline GERN GERON CORP More: the full row for GERON CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 500,000 shares; 2025Q2: 1,000,000 shares; 2025Q3: 1,600,000 shares; 2025Q4: 805,800 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 20,000 shares 20,000 $24.6K 0.02% new Timeline